129 results
8-K
EX-99.1
AGRX
Agile Therapeutics Inc
9 Apr 24
Results of Operations and Financial Condition
8:30am
Targeting “Big 5” States Agile continues to focus its Twirla promotional efforts on five states that have high levels of reimbursement potential
8-K
EX-99.1
sfe71at
9 Nov 23
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
8:15am
8-K
EX-10.1
y97za7zmn 7xox2
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
8-K/A
nfhn yvy1npx5
22 Aug 23
Departure of Directors or Certain Officers
8:30am
8-K/A
EX-10.1
pjdj6v6flwvhe59z
22 Aug 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-99.1
yksnj12wek42j665rw4y
9 Aug 23
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
8-K
he2znx0iv8ao
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-10.1
s369f12h9m1pew3h
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
424B4
dutha5kwyb8 u4k6i4gp
24 May 23
Prospectus supplement with pricing info
4:05pm